Brief: Protara Therapeutics Q1 Loss Per Share $0.96
05/05/2022 13:55
May 5 (Reuters) - Protara Therapeutics Inc TARA.O :
* Q1 LOSS PER SHARE $0.96
* PROTARA - STRONG CASH, CASH EQUIVALENTS AND INVESTMENTS
POSITION
OF $119 MILLION AS OF MARCH 31, 2022 EXPECTED TO FUND OPERATIONS
INTO MID-2024
* QTRLY LOSS PER SHARE $0.96
Source text for Eikon: ID:nGNX5PLDrw
Further company coverage: TARA.O
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses